MAPT and Alzheimer disease: Thus, there is still ongoing intense debate on whether it is the accumulation of Aβ or hyperphosphorylated tau that initiates AD, which one is more strongly associated with the progression of AD, and which should be targeted for therapeutic drugs43,44.